NCAM1 and small cell lung carcinoma: Coherently, whole-exome sequencing validated that CD56+ CTC show typical genomic alterations and classical altered pathways commonly found in SCLC (e.g. TP53 mutation, RB1 loss) but they are also characterized by distinct mutational patterns.